CAJ | 학술논문

目的：观察并评价托特罗定治疗Ⅲ型前列腺炎疗效和安全性。方法将80例Ⅲ型慢性前列腺炎的门诊患者随机分为两组，每组各40例，两组均使用左氧氟沙星治疗，其中A组加用托特罗定和中成药（前列舒通）治疗， B组仅加用中成药（前列舒通）治疗。治疗6～8周后，通过NIH-CPSI评分评价两组治疗方法对患者的疗效。结果治疗后A组有效34例，有效率85％，B组有效24例，有效率60％，A组有效率高于B组（P＜0．05）。结论对于Ⅲ型前列腺炎患者，托特罗定可明显改善患者排尿症状，且不良反应较低，患者耐受性较好。
목적：관찰병평개탁특라정치료Ⅲ형전렬선염료효화안전성。방법장80례Ⅲ형만성전렬선염적문진환자수궤분위량조，매조각40례，량조균사용좌양불사성치료，기중A조가용탁특라정화중성약（전렬서통）치료， B조부가용중성약（전렬서통）치료。치료6～8주후，통과NIH-CPSI평분평개량조치료방법대환자적료효。결과치료후A조유효34례，유효솔85％，B조유효24례，유효솔60％，A조유효솔고우B조（P＜0．05）。결론대우Ⅲ형전렬선염환자，탁특라정가명현개선환자배뇨증상，차불량반응교저，환자내수성교호。
Objective To evaluate the efficacy and safety of tolterodine for the treatment of men with chronic prostatitis ( typeⅢ) . Methods Eighty men with chronic prostatitis ( type Ⅲ) were randomly assigned to receive a Chinese medicine ( n=40 ) or both tolterodine and a Chinese medicine(n=40) for 6 to 8 weeks.All the patients received oral levofloxacin simultaneously .Patient perception of treatment benefit ,adverse reaction and NIH-CPSI were assessed .Results Patients receiving both tolterodine and a Chinese medicine demonstrated sig-nificant improvement on NIH-CPSI than those receiving only a Chinese medicine .Conclusion Tolterodine can improve the urinary symptom effectively for men with prostatitis .